Evidence map›Paper›PMID 34439507›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Malaria Pigment Hemozoin Impairs GM-CSF Receptor Expression and Function by 4-Hydroxynonenal.

Oleksii Skorokhod, Valentina Barrera, Giorgia Mandili, Federica Costanza, Elena Valente, Daniela Ulliers, Evelin Schwarzer

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Application of a Non-Targeted Metabolomics Study inInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oleksii SkorokhodDepartment of Life Sciences and Systems Biology, University of Torino, 10123 Torino, Italy.ORCID 0000-0003-1014-8351
Valentina BarreraDepartment of Oncology, University of Torino, 10126 Torino, Italy.
Giorgia MandiliDepartment of Oncology, University of Torino, 10126 Torino, Italy.
Federica CostanzaDepartment of Oncology, University of Torino, 10126 Torino, Italy.
Elena ValenteDepartment of Oncology, University of Torino, 10126 Torino, Italy.
Daniela UlliersDepartment of Oncology, University of Torino, 10126 Torino, Italy.
Evelin SchwarzerDepartment of Oncology, University of Torino, 10126 Torino, Italy.ORCID 0000-0003-2791-1894

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malarial pigment hemozoin (HZ) generates the lipoperoxidation product 4-hydroxynonenal (4-HNE), which is known to cause dysregulation of the immune response in malaria. The inhibition of granulocyte macrophage colony-stimulating factor (GM-CSF)-dependent differentiation of dendritic cells (DC) by HZ and 4-HNE was previously described in vitro, and the GM-CSF receptor (GM-CSF R) was hypothesised to be a primary target of 4-HNE in monocytes. In this study, we show the functional impact of HZ on GM-CSF R in monocytes and monocyte-derived DC by (i) impairing GM-CSF binding by 50 ± 9% and 65 ± 14%, respectively (

Indexed as

4-hydroxynonenalCD116dendritic cellgranulocyte-macrophage colony-stimulating factor receptorhemozoinmalariamonocyte

Identifiers

PMID34439507
PMCPMC8389202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.